Literature DB >> 32331769

Depression and Inflammation in Patients With Lung Cancer: A Comparative Analysis of Acute Phase Reactant Inflammatory Markers.

Daniel C McFarland1, William Breitbart2, Andrew H Miller3, Christian Nelson2.   

Abstract

BACKGROUND: Depression and inflammation are intertwined, which is particularly relevant for patients with lung cancer who have an abundance of inflammation and experience depression. Acute phase reactants (APRs), albumin and C-reactive protein (CRP), are easily interpretable indirect markers of inflammation that have never been concomitantly compared with depression. Inflammation increases CRP (positive APR) and decreases albumin (negative APR). We hypothesize that albumin will be similarly associated with depression, thereby helping to inform the diagnosis of inflammatory depression.
OBJECTIVE: Compares the relationship between depression and representative positive and negative acute phase reactants in patients with metastatic lung cancer.
METHODS: Patients (n = 109) with metastatic lung cancer were evaluated for depression using the Hospital Anxiety and Depression Scale. Inflammation as measured by positive (CRP) and negative (albumin) APRs along with demographic and treatment variables were analyzed for associations with depression.
RESULTS: Depression was associated with lower albumin (r = -0.35, P < 0.001), higher CRP (r = 0.47, P < 0.001), and the CRP/albumin ratio (r = 0.45, P < 0.001). Hierarchical linear regression modeling found that albumin was associated with depression when controlling for demographics, disease, and treatment types (β = -0.28, P = 0.01). When both APRs were in the model, only CRP predicted depression (β = 0.31, P = 0.01), and albumin did not moderate CRP and depression. CRP/albumin ratio did not add to understanding depression variability, but patients with both low albumin and high CRP had particularly severe depression.
CONCLUSION: Albumin is associated with depression but not to a greater extent than CRP. The coupling of lower albumin and higher CRP describes more severe depression. Positive and negative APRs may form a distinct biologic signature to help identify patients with inflammatory depression in the lung cancer setting.
Copyright © 2020 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C reactive protein; acute phase reactants; albumin; cancer; depression; lung cancer

Mesh:

Substances:

Year:  2020        PMID: 32331769      PMCID: PMC7529727          DOI: 10.1016/j.psym.2020.03.005

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  40 in total

1.  The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.

Authors:  Tim J Hartung; Michael Friedrich; Christoffer Johansen; Hans-Ulrich Wittchen; Herman Faller; Uwe Koch; Elmar Brähler; Martin Härter; Monika Keller; Holger Schulz; Karl Wegscheider; Joachim Weis; Anja Mehnert
Journal:  Cancer       Date:  2017-06-27       Impact factor: 6.860

2.  Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus.

Authors:  Stefania Bonaccorso; Valentina Marino; Massimo Biondi; Franca Grimaldi; Flora Ippoliti; Michael Maes
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

3.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

Authors:  E M Macy; T E Hayes; R P Tracy
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

Review 4.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Authors:  Ingvar Bjelland; Alv A Dahl; Tone Tangen Haug; Dag Neckelmann
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

5.  Serum IL-6, albumin and co-morbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis.

Authors:  Kuo-Chin Hung; Chia-Chao Wu; Hsiao-Shuang Chen; Wen-Ya Ma; Chin-Feng Tseng; Lai-King Yang; Hsiang-Li Hsieh; Kuo-Cheng Lu
Journal:  Nephrol Dial Transplant       Date:  2010-07-14       Impact factor: 5.992

Review 6.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

7.  Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation.

Authors:  H J Moshage; J A Janssen; J H Franssen; J C Hafkenscheid; S H Yap
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  Albumin and depression in elderly stroke survivors: An observational cohort study.

Authors:  Michaela C Pascoe; Ingmar Skoog; Christian Blomstrand; Thomas Linden
Journal:  Psychiatry Res       Date:  2015-10-22       Impact factor: 3.222

9.  Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.

Authors:  N Kappelmann; G Lewis; R Dantzer; P B Jones; G M Khandaker
Journal:  Mol Psychiatry       Date:  2016-10-18       Impact factor: 15.992

10.  Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.

Authors:  A M H Krebber; L M Buffart; G Kleijn; I C Riepma; R de Bree; C R Leemans; A Becker; J Brug; A van Straten; P Cuijpers; I M Verdonck-de Leeuw
Journal:  Psychooncology       Date:  2013-09-16       Impact factor: 3.894

View more
  6 in total

1.  Potential use of albumin and neutrophil-to-lymphocyte ratio to guide the evaluation and treatment of cancer-related depression and anxiety.

Authors:  Daniel C McFarland; Allison J Applebaum; Erik Bengtsen; Yesne Alici; William Breitbart; Andrew H Miller; Christian Nelson
Journal:  Psychooncology       Date:  2021-09-04       Impact factor: 3.955

2.  Molecular clustering based on gene set expression and its relationship with prognosis in patients with lung adenocarcinoma.

Authors:  Baobao Xing; Lei Shi; Zhiguo Bao; Ying Liang; Bo Liu; Ruihan Liu
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

3.  Prognostic implications of depression and inflammation in patients with metastatic lung cancer.

Authors:  Daniel C McFarland; Rebecca M Saracino; Andrew H Miller; William Breitbart; Barry Rosenfeld; Christian Nelson
Journal:  Future Oncol       Date:  2020-12-11       Impact factor: 3.404

4.  Application of Narrative Nursing Combined With Focused Solution Model to Anxiety and Depression in Patients With Lung Tumor During Perioperative Period.

Authors:  Jing Feng; Ling Ge; Fengxia Jin; Li Jiang
Journal:  Front Surg       Date:  2022-04-08

5.  The relationship between Comprehensive Geriatric Assessment parameters and depression in elderly patients.

Authors:  Yanmin Ju; Ting Liu; Kexin Zhang; Xiaoye Lin; Enlai Zheng; Jiyan Leng
Journal:  Front Aging Neurosci       Date:  2022-07-26       Impact factor: 5.702

6.  Neutrophil to Lymphocyte Ratio in Lung Cancer: Implications for Depressive Symptoms and Survival.

Authors:  Daniel C McFarland
Journal:  Clin Oncol Res       Date:  2020-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.